Emerald Advisers’s Treace Medical Concepts TMCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,561,893	Closed	-$20.4M	–	270
2024 Q1	$20.4M	Buy	1,561,893 +114,304	+8%	+$1.52M	0.82%	49
2023 Q4	$18.5M	Sell	1,447,589 -25,692	-2%	-$260K	0.79%	52
2023 Q3	$19.3M	Buy	1,473,281 +107,143	+8%	+$1.96M	0.94%	41
2023 Q2	$34.9M	Buy	1,366,138 +2,685	+0.2%	+$69.3K	1.53%	8
2023 Q1	$34.3M	Buy	1,363,453 +175,207	+15%	+$4.11M	1.65%	7
2022 Q4	$27.3M	Buy	1,188,246 +67,481	+6%	+$1.55M	1.32%	20
2022 Q3	$24.7M	Buy	1,120,765 +51,881	+5%	+$1M	1.28%	22
2022 Q2	$15.3M	Buy	1,068,884 +196,605	+23%	+$3.31M	0.79%	50
2022 Q1	$16.5M	Buy	872,279 +493,351	+130%	+$9.59M	0.63%	66
2021 Q4	$7.06M	Buy	378,928 +107,051	+39%	+$2.21M	0.26%	109
2021 Q3	$7.31M	Buy	271,877 +1,470	+0.5%	+$40.4K	0.27%	108
2021 Q2	$8.45M	Buy	+270,407	New	+$8.61M	0.31%	107